_menuCloseDelay=500;
_menuOpenDelay=150;
_subOffsetTop=2;
_subOffsetLeft=-2;
buildafterload="true";


with(submenuStyle=new mm_style()){
bordercolor="#ACABAB";
borderstyle="solid";
borderwidth="1";
fontfamily="Trebuchet MS";
fontsize="8pt";
fontstyle="normal";
fontweight="normal";
headercolor="#000000";
offbgcolor="Maroon";
offcolor="White";
onbgcolor="#ffffff";
oncolor="#7B7B7A";
outfilter="Blinds( Bands=1,direction=down, duration=0.5)";
overfilter="Blinds( Bands=1,direction=up, duration=0.3)";
padding="3";
separatorcolor="#ffffff";
separatorsize="1";
subimagepadding="8";
}

with(menuStyle=new mm_style()){
bordercolor="#ACABAB";
borderstyle="solid";
borderwidth="0";
fontfamily="Trebuchet MS";
fontsize="10pt";
fontstyle="normal";
fontweight="bold";
headerbgcolor="#ffffff";
headercolor="#000000";
image="images/orangedots.gif";
offbgcolor="Linen";
offcolor="Black";
onbgcolor="LightGrey";
oncolor="FloralWhite";
outfilter="Fade(Overlap=1.00)";
padding="4";
separatorcolor="Transparent";
separatorsize="2";
subimagepadding="8";
overimage="images/orangedots.gif";
imagepadding="6";
itemwidth="160";
}

with(milonic=new menuname("Main Menu")){
position="relative";
style=menuStyle;
alwaysvisible="1";
aI("text=Home;target=;url=http://www.mentorcapital.com/;");
aI("text=Changing Assets & Acquisitions;target=;url=Changing-Assets-&-Acquisitions.html;");
aI("text=Warrant Information;target=;url=Warrant-Information.html;");
aI("showmenu=Chairman's Letters/Bringing It All Together To Win In The Cancer Fight  (2011)LEFT_MENU;text=Chairman's Letters;target=;url=Chairman's-Letters.html;");
aI("showmenu=Medicine, Science & The Economy/Sunlight Explains Japan Radiation RiskLEFT_MENU;text=Medicine, Science & The Economy;target=;url=Medicine,-Science-&-The-Economy.html;");
aI("showmenu=Press Releases/Mentor Capital Acquires 50 Percent of Brighter Day Health For $5MLEFT_MENU;text=Press Releases;target=;url=Press-Releases.html;");
aI("text=Cancer Resources;target=;url=Cancer-Resources.html;");
aI("text=Information For Brokers;target=;url=Information-For-Brokers.html;");
aI("text=Shareholder Updates;target=;url=Shareholder-Updates.html;");
aI("text=FAQ;target=;url=Frequently-Asked-Questions.html;");
aI("text=Contact Us;target=;url=Contact-Mentor-Capital,-Inc.html;");
}

with(milonic=new menuname("Chairman's Letters/Bringing It All Together To Win In The Cancer Fight  (2011)LEFT_MENU")){
style=submenuStyle;
aI("text=Bringing It All Together To Win In The Cancer Fight  (2011);target=;url=Bringing-It-All-Together-To-Win-In-The-Cancer-Fight-(2011).html;");
aI("text=Welcome To The Team Leading The Cancer Fight (2010);target=;url=Welcome-To-The-Team-Leading-The-Cancer-Fight-(2010).html;");
}

with(milonic=new menuname("Medicine, Science & The Economy/Sunlight Explains Japan Radiation RiskLEFT_MENU")){
style=submenuStyle;
aI("text=Sunlight Explains Japan Radiation Risk;target=;url=Sunlight-Explains-Japan-Radiation-Risk.html;");
}

with(milonic=new menuname("Press Releases/Mentor Capital Acquires 50 Percent of Brighter Day Health For $5MLEFT_MENU")){
style=submenuStyle;
aI("text=Mentor Capital Acquires 50 Percent of Brighter Day Health For $5M;target=;url=Mentor-Capital-Acquires-50-Percent-of-Brighter-Day-Health-For-$5M.html;");
aI("text=Mentor Capital Begins its 2012 Cancer Roll-up Strategy;target=;url=Mentor-Capital-Begins-its-2012-Cancer-Roll-up-Strategy.html;");
aI("text=MNTR acquires 30 Percent of European Cancer Vaccine for $4.71 Million;target=;url=MNTR-acquires-30-Percent-of-European-Cancer-Vaccine-for-$4.71-Million.html;");
aI("text=Mentor Capital Adds to European Cancer Portfolio with AGI Biopharmaceuticals Melanoma Vaccine;target=;url=Mentor-Capital-Adds-to-European-Cancer-Portfolio-with-AGI-Biopharmaceuticals-Melanoma-Vaccine.html;");
aI("text=Mentor Capital Reports Mid-Year Profits for 2011;target=;url=Mentor-Capital-Reports-Mid-Year-Profits-for-2011.html;");
aI("text=Mentor Capital Initiates Discussions for Potential Merger;target=;url=Mentor-Capital-Initiates-Discussions-for-Potential-Merger.html;");
aI("text=Mentor Capital Seeks Funding Partners as Neutron Cancer Therapy Accelerates;target=;url=Mentor-Capital-Seeks-Funding-Partners-as-Neutron-Cancer-Therapy-Accelerates.html;");
aI("text=Cancer Immunotherapy Index Outpaces Biotechs;target=;url=Cancer-Immunotherapy-Index-Outpaces-Biotechs.html;");
aI("text=Increased Chinese and International Visitors to Mentor Capital Site;target=;url=Increased-Chinese-and-International-Visitors-to-Mentor-Capital-Site.html;");
aI("text=CEO Purchases an Additional 3.14% of MNTR Shares;target=;url=CEO-Purchases-an-Additional-3.14-Percent-of-MNTR-Shares.html;");
aI("text=MNTR Drafts Five Cancer Funding Contracts for $40 Million;target=;url=MNTR-Drafts-Five-Cancer-Funding-Contracts-for-$40-Million.html;");
aI("text=MNTR Screens Cancer Companies For Investment At ASCO;target=;url=MNTR-Screens-Cancer-Companies-For-Investment-At-ASCO.html;");
aI("text=MNTR Acquires $5M Hadron Neutron Therapy Interest;target=;url=MNTR-Acquires-$5M-Hadron-Neutron-Therapy-Interest.html;");
aI("text=$125 Million for Socially Responsible Direct Cancer Funding;target=;url=$125-Million-for-Socially-Responsible-Direct-Cancer-Funding.html;");
aI("text=Advaxis Added To Cancer Immunotherapy Index;target=;url=Advaxis-Added-To-Cancer-Immunotherapy-Index.html;");
aI("text=MNTR In Discussion With Breast Cancer Immunotherapy Company;target=;url=MNTR-In-Discussion-With-Breast-Cancer-Immunotherapy-Company.html;");
aI("text=Nobel Laureate Reinforces the Mentor Capital Strategy to Fund Only Leading-edge Cancer Science;target=;url=Nobel-Laureate-Reinforces-the-Mentor-Capital-Strategy-to-Fund.html;");
aI("text=Mentor Capital to Expand Funding Bridge Over Cancer Development Gap;target=;url=Mentor-Capital-to-Expand-Funding-Bridge-Over-Cancer-Development-Gap.html;");
aI("text=Mentor Capital Cancer Immunotherapy Index Gains on Medicare Advisory Committee Approval;target=;url=Mentor-Capital-Cancer-Immunotherapy-Index-Gains-on-Medicare-Advisory-Committee-Approval-of-$93,000-Provenge-Immunotherapy-Treatment-by-Dendreon-f.html;");
aI("text=MNTR Sees Shift To Public Acceptance;target=;url=Mentor-Capital-Sees-a-Shift-to-Public-Acceptance-of-Dendreon-like.html;");
aI("text=Cancer Index at New High with 12 Yr Exclusive Period in Health Bill;target=;url=Mentor-Capital-Cancer-Immunotherapy-Index-Gains-on-Health-Care-Bill-12-Year-Exclusive-Period-for-Biologic-Drugs.html;");
aI("text=Provectus Pharmaceuticals (PVCT) added to Cancer Immunotherapy Index;target=;url=Provectus-Pharmaceuticals,-Inc.-Added-to-Cancer-Immunotherapy-Index-by-Mentor-Capital,-Inc.-Experiences-23-Percent-One-Week-Gain.html;");
aI("text=MNTR Invests in 10 Cancer Index Companies;target=;url=Mentor-Capital-Takes-Investment-Position-in-Each-of-10-Cancer-Immunotherapy-Index-Companies.html;");
aI("text=MNTR Retains Investment Bank to Assist Roll Out Cancer Immunotherapy Index Fund;target=;url=Mentor-Capital-Retains-Network-1-Financial-Securities-for-Comprehensive-Investment-Banking-Services.html;");
aI("text=2010 Actively Managed Cancer Immunotherapy Index Announced by MNTR;target=;url=Mentor-Capital-Announces-Plan-for-New-2010-Actively-Managed-Cancer-Immunotherapy-Index-and-45-Day-Call-on-C-Warrants-for-CI-Index-Seed-Funding.html;");
aI("text=MNTR Presents in NYC;target=;url=Mentor-Capital,-Inc.-Speaks-on-Cancer-Investment-with-Long-Island-Investment-Banking-Group.html;");
aI("text=QI Announces MNTR;target=;url=Quantum-Immunologics-Achieves-Major-Funding-in-Support-of-Ongoing-FDA-Trials.html;");
aI("text=MNTR Calls  $3 Million Tranche;target=;url=Mentor-Capital,-Inc.-Gains-135-Percent-and-Calls-in-$3-Million-Equity-Tranche.html;");
aI("text=MNTR Initiates Trading;target=;url=Mentor-Capital,-Inc.-(MNTR)-Initiates-Trading-at-$1.05-sh-(P-E-of-2.7x).html;");
}


 drawMenus();